NewslettersMesenchymal Cell NewsPropranolol Blocks Osteosarcoma Cell Cycle Progression, Inhibits Angiogenesis and Slows Xenograft Growth in Combination with Cisplatin-Based ChemotherapyBy Bob - September 13, 20220233Researchers evaluated the antitumoral activity of propranolol using different in vitro and in vivo osteosarcoma preclinical models, alone or in addition to chemotherapy.[Scientific Reports]Full Article